Lv1
20 积分 2023-11-08 加入
Microbes in lung cancer initiation, treatment, and outcome: Boon or bane?
10小时前
待确认
Hypoxic and acidic tumor microenvironment-driven AVL9 promotes chemoresistance of pancreatic ductal adenocarcinoma via the AVL9-IκBα-SKP1 complex
1天前
已完结
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study
17天前
已完结
Fat and Furious: Lipid Metabolism in Antitumoral Therapy Response and Resistance
3个月前
已完结
Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours
4个月前
已完结
PD-1 maintains CD8 T cell tolerance towards cutaneous neoantigens
8个月前
已完结
DEAD-box proteins: the driving forces behind RNA metabolism
11个月前
已完结
Complement-ary immunity to lung cancer
11个月前
已关闭
Silencing EGFR-upregulated expression of CD55 and CD59 activates the complement system and sensitizes lung cancer to checkpoint blockade
1年前
已完结
Targeting KRAS in non-small-cell lung cancer: recent progress and new approaches
1年前
已完结
皖公网安备34019202002308
